Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Molecular multitasking: statins lead to more arteries, less plaque

Nature Medicine volume 6, pages 965–966 (2000)Cite this article

Statins, commonly prescribed cholesterol-lowering drugs, have also been identified as anti-oxidants, anti-inflammatories and now, as angiogenic agents. Elucidation of the statin signal transduction pathway should reveal how one class of drugs can have so many activities (pages 1004–1010).

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Simvastatin, Akt signaling and angiogenesis.

References

  1. Vaughan, C.J., Murphy, M.B. & Buckley, B.M. Statins do more than just lower cholesterol. Lancet 348, 1079–1082 ( 1996).

    Article  CAS  Google Scholar 

  2. Davignon, J. & Laaksonen, R. Low-density lipoprotein-independent effects of statins. Curr. Opin. Lipidol. 10, 543–559 (1999).

    Article  CAS  Google Scholar 

  3. Kureishi, Y. et al. The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals . Nature Med. 6, 1004–1010

  4. Dimmeler, S. & Zeiher, A.M. Akt takes center stage in angiogenesis signaling. Circ. Res. 86, 4– 5 (2000).

    Article  CAS  Google Scholar 

  5. Jiang, B.H., Zheng, J.Z., Aoki, M. & Vogt, P.K. Phosphatidylinositol 3-kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells. Proc. Natl. Acad. Sci. USA 97, 1749–1753 ( 2000).

    Article  CAS  Google Scholar 

  6. Eliceiri, B.P. et al. Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability. Mol. Cell. 4, 915–924 (1999).

    Article  CAS  Google Scholar 

  7. Endres, M. et al. Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. Proc. Natl. Acad. Sci. USA 95, 8880–8885 (1998).

    Article  CAS  Google Scholar 

  8. Lefer, A.M. et al. Simvastatin preserves the ischemic-reperfused myocardium in normocholesterolemic rat hearts. Circulation 100, 178–184 (1999).

    Article  CAS  Google Scholar 

  9. Laufs, U., La Fata, V., Plutzky, J. & Liao, J.K. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 97, 1129–1135 (1998).

    Article  CAS  Google Scholar 

  10. Lopez, J. et al. Hemodynamic effects of intracoronary VEGF delivery: evidence of tachyphylaxis and NO dependence of response. Am. J. Physiol. 273, H1317–1323 ( 1997).

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Angiogenesis Research Center Beth Israel Deaconess Medical Center, RW-453330 Brookline Ave, Boston, 02215, Massachussetts

    Michael Simons

Authors
  1. Michael Simons
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Simons, M. Molecular multitasking: statins lead to more arteries, less plaque. Nat Med 6, 965–966 (2000). https://doi.org/10.1038/79646

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/79646

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing